ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for ATRC

Stock NameAtriCure Inc
TickerATRC(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS04963C2098

Show aggregate ATRC holdings

News associated with ATRC

AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of “Buy” from Brokerages
AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) has been given a consensus recommendation of “Buy” by the nine brokerages that are covering the stock, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have issued ratings on the stock in the last […] - 2025-08-22 02:26:44
AtriCure, Inc. (NASDAQ:ATRC) Short Interest Up 46.1% in July
AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) saw a significant increase in short interest during the month of July. As of July 31st, there was short interest totaling 2,220,000 shares, anincreaseof46.1% from the July 15th total of 1,520,000 shares. Based on an average daily volume of 546,100 shares, the short-interest ratio is presently 4.1 days. […] - 2025-08-21 05:28:44
XTX Topco Ltd Makes New $526,000 Investment in AtriCure, Inc. (NASDAQ:ATRC)
XTX Topco Ltd purchased a new position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) during the first quarter, Holdings Channel reports. The firm purchased 16,301 shares of the medical device company’s stock, valued at approximately $526,000. A number of other hedge funds also recently bought and sold shares of the business. Hood River […] - 2025-08-07 05:01:01
Mackenzie Financial Corp Increases Position in AtriCure, Inc. (NASDAQ:ATRC)
Mackenzie Financial Corp lifted its holdings in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 91.6% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 29,143 shares of the medical device company’s stock after acquiring an additional 13,929 shares during the quarter. Mackenzie Financial […] - 2025-08-06 05:07:47
AtriCure (NASDAQ:ATRC) Shares Gap Up on Strong Earnings
AtriCure, Inc. (NASDAQ:ATRC – Get Free Report)’s stock price gapped up prior to trading on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $31.73, but opened at $37.70. AtriCure shares last traded at $37.03, with a volume of 594,302 shares traded. The medical device company reported ($0.02) […] - 2025-08-01 02:07:09
Allianz Asset Management GmbH Has $3.96 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC)
Allianz Asset Management GmbH lifted its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 22.8% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 122,858 shares of the medical device company’s stock after acquiring an additional 22,838 shares during the period. Allianz Asset Management GmbH owned […] - 2025-07-29 04:44:56
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Recommendation of “Buy” from Analysts
AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) has been given a consensus recommendation of “Buy” by the nine ratings firms that are covering the stock, Marketbeat Ratings reports. Nine research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokerages that have updated their coverage on the stock […] - 2025-07-28 03:06:51
Mackenzie Financial Corp Takes Position in AtriCure, Inc. (NASDAQ:ATRC)
Mackenzie Financial Corp acquired a new position in AtriCure, Inc. (NASDAQ:ATRC – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 15,214 shares of the medical device company’s stock, valued at approximately $465,000. Other institutional investors and hedge funds have also […] - 2025-06-04 05:16:59
AtriCure (NASDAQ:ATRC) Stock Rating Lowered by Wall Street Zen
Wall Street Zen cut shares of AtriCure (NASDAQ:ATRC – Free Report) from a buy rating to a hold rating in a research report released on Sunday morning. A number of other analysts also recently weighed in on ATRC. Piper Sandler upped their target price on shares of AtriCure from $40.00 to $50.00 and gave the […] - 2025-06-02 04:26:45
AtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Squarepoint Ops LLC
Squarepoint Ops LLC cut its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 64.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,472 shares of the medical device company’s stock after selling 101,207 shares during the […] - 2025-05-30 05:35:00
State of Wyoming Acquires 446 Shares of AtriCure, Inc. (NASDAQ:ATRC)
State of Wyoming boosted its position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 21.9% in the 4th quarter, HoldingsChannel reports. The firm owned 2,481 shares of the medical device company’s stock after buying an additional 446 shares during the period. State of Wyoming’s holdings in AtriCure were worth $76,000 at the end […] - 2025-05-29 05:08:55
ProShare Advisors LLC Increases Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC)
ProShare Advisors LLC grew its stake in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 49.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,330 shares of the medical device company’s stock after purchasing an additional 4,385 shares during the quarter. ProShare […] - 2025-05-28 05:13:03
Man Group plc Invests $745,000 in AtriCure, Inc. (NASDAQ:ATRC)
Man Group plc purchased a new position in AtriCure, Inc. (NASDAQ:ATRC – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 24,368 shares of the medical device company’s stock, valued at approximately $745,000. Other institutional investors and hedge funds […] - 2025-05-26 05:01:05
AtriCure (NASDAQ:ATRC) Stock Rating Upgraded by Wall Street Zen
AtriCure (NASDAQ:ATRC – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday. A number of other analysts have also commented on ATRC. Stifel Nicolaus boosted their price objective on shares of AtriCure from $36.00 to $48.00 and gave […] - 2025-05-26 02:12:50
ATRC Crosses Below Key Moving Average Level
In trading on Friday, shares of AtriCure Inc (Symbol: ATRC) crossed below their 200 day moving average of $32.37, changing hands as low as $31.95 per share. AtriCure Inc shares are currently trading down about 0.8% on the day. The chart below shows the one year performance of - 2025-05-23 12:36:54
Nuveen Asset Management LLC Sells 149,584 Shares of AtriCure, Inc. (NASDAQ:ATRC)
Nuveen Asset Management LLC decreased its position in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 12.6% during the fourth quarter, HoldingsChannel.com reports. The firm owned 1,037,348 shares of the medical device company’s stock after selling 149,584 shares during the quarter. Nuveen Asset Management LLC’s holdings in AtriCure were worth $31,701,000 as of its most recent […] - 2025-05-22 05:58:59
BNP Paribas Financial Markets Has $2.97 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC)
BNP Paribas Financial Markets lifted its position in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 676.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 97,310 shares of the medical device company’s stock after buying an additional 84,776 […] - 2025-05-16 06:02:57
Northern Trust Corp Increases Holdings in AtriCure, Inc. (NASDAQ:ATRC)
Northern Trust Corp grew its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 11.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 483,607 shares of the medical device company’s stock after purchasing an additional 50,153 shares during the […] - 2025-05-16 04:38:56
Dimensional Fund Advisors LP Raises Position in AtriCure, Inc. (NASDAQ:ATRC)
Dimensional Fund Advisors LP increased its stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 24.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 700,212 shares of the medical device company’s stock after acquiring an additional 136,015 shares during the quarter. Dimensional Fund Advisors LP’s holdings in AtriCure were worth $21,398,000 […] - 2025-05-08 04:45:00
Barclays PLC Has $2.64 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC)
Barclays PLC trimmed its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 33.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 86,541 shares of the medical device company’s stock after selling 42,724 shares during the quarter. Barclays PLC’s holdings in AtriCure were worth […] - 2025-05-01 05:14:58
AtriCure (NASDAQ:ATRC) Trading Up 4.9% After Better-Than-Expected Earnings
AtriCure, Inc. (NASDAQ:ATRC – Get Free Report)’s share price traded up 4.9% on Tuesday following a stronger than expected earnings report. The company traded as high as $35.19 and last traded at $35.31. 373,568 shares were traded during mid-day trading, a decline of 43% from the average session volume of 654,896 shares. The stock had […] - 2025-05-01 02:40:58
Envestnet Asset Management Inc. Cuts Position in AtriCure, Inc. (NASDAQ:ATRC)
Envestnet Asset Management Inc. decreased its stake in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 4.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 46,086 shares of the medical device company’s stock after selling 2,104 shares during the period. Envestnet Asset Management […] - 2025-04-30 04:42:56
Raymond James Financial Inc. Acquires Shares of 121,591 AtriCure, Inc. (NASDAQ:ATRC)
Raymond James Financial Inc. acquired a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 121,591 shares of the medical device company’s stock, valued at approximately $3,716,000. Several other hedge […] - 2025-04-27 06:26:45
AtriCure (NASDAQ:ATRC) and KORU Medical Systems (NASDAQ:KRMD) Financial Survey
AtriCure (NASDAQ:ATRC – Get Free Report) and KORU Medical Systems (NASDAQ:KRMD – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, profitability, risk and dividends. Valuation and Earnings This table compares AtriCure […] - 2025-04-22 02:50:55
Townsquare Capital LLC Decreases Stake in AtriCure, Inc. (NASDAQ:ATRC)
Townsquare Capital LLC decreased its holdings in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 4.7% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 16,138 shares of the medical device company’s stock after selling 789 shares during the period. Townsquare Capital LLC’s holdings in AtriCure were worth $493,000 […] - 2025-04-21 05:26:42
JPMorgan Chase & Co. Buys 110,039 Shares of AtriCure, Inc. (NASDAQ:ATRC)
JPMorgan Chase & Co. increased its stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 43.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 365,183 shares of the medical device company’s stock after acquiring an additional 110,039 shares during the quarter. JPMorgan Chase & Co.’s holdings in AtriCure were worth $11,160,000 […] - 2025-04-14 04:39:04
Corebridge Financial Inc. Reduces Holdings in AtriCure, Inc. (NASDAQ:ATRC)
Corebridge Financial Inc. lowered its stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 7.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,535 shares of the medical device company’s stock after selling 1,776 shares during the quarter. Corebridge Financial Inc.’s […] - 2025-04-07 04:32:51
Analysts Set AtriCure, Inc. (NASDAQ:ATRC) Target Price at $51.56
Shares of AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) have earned an average recommendation of “Buy” from the nine analysts that are currently covering the firm, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have issued ratings on the stock in the […] - 2025-03-28 04:56:46
Needham & Company LLC Reaffirms “Buy” Rating for AtriCure (NASDAQ:ATRC)
Needham & Company LLC reaffirmed their buy rating on shares of AtriCure (NASDAQ:ATRC – Free Report) in a research report sent to investors on Friday,Benzinga reports. They currently have a $51.00 price target on the medical device company’s stock. Several other analysts also recently commented on ATRC. JMP Securities reaffirmed a “market outperform” rating and […] - 2025-03-24 04:34:46
Analysts See 32% Gains Ahead For The Holdings of ESML
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-12 09:42:28

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc ATRC holdings

DateNumber of ATRC Shares HeldBase Market Value of ATRC SharesLocal Market Value of ATRC SharesChange in ATRC Shares HeldChange in ATRC Base ValueCurrent Price per ATRC Share HeldPrevious Price per ATRC Share Held
2025-12-11 (Thursday)34,085USD 1,411,460ATRC holding increased by 7840USD 1,411,4600USD 7,840 USD 41.41 USD 41.18
2025-12-10 (Wednesday)34,085USD 1,403,620ATRC holding increased by 49764USD 1,403,6200USD 49,764 USD 41.18 USD 39.72
2025-12-09 (Tuesday)34,085USD 1,353,856ATRC holding increased by 26586USD 1,353,8560USD 26,586 USD 39.72 USD 38.94
2025-12-08 (Monday)34,085USD 1,327,270ATRC holding decreased by -31358USD 1,327,2700USD -31,358 USD 38.94 USD 39.86
2025-12-05 (Friday)34,085USD 1,358,628ATRC holding increased by 20792USD 1,358,6280USD 20,792 USD 39.86 USD 39.25
2025-12-04 (Thursday)34,085USD 1,337,836ATRC holding increased by 100210USD 1,337,8360USD 100,210 USD 39.25 USD 36.31
2025-12-03 (Wednesday)34,085ATRC holding decreased by -595USD 1,237,626ATRC holding increased by 13075USD 1,237,626-595USD 13,075 USD 36.31 USD 35.31
2025-12-02 (Tuesday)34,680ATRC holding increased by 238USD 1,224,551ATRC holding increased by 15981USD 1,224,551238USD 15,981 USD 35.31 USD 35.09
2025-12-01 (Monday)34,442USD 1,208,570ATRC holding decreased by -35475USD 1,208,5700USD -35,475 USD 35.09 USD 36.12
2025-11-28 (Friday)34,442USD 1,244,045ATRC holding increased by 3100USD 1,244,0450USD 3,100 USD 36.12 USD 36.03
2025-11-27 (Thursday)34,442USD 1,240,945USD 1,240,9450USD 0 USD 36.03 USD 36.03
2025-11-26 (Wednesday)34,442USD 1,240,945ATRC holding decreased by -84383USD 1,240,9450USD -84,383 USD 36.03 USD 38.48
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ATRC by Blackrock for IE00B3VWM098

Show aggregate share trades of ATRC

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-12-03SELL-59536.32034.985 35.119USD -20,896 34.37 Loss of -447 on sale
2025-12-02BUY23836.19034.875 35.006USD 8,332 34.36
2025-11-25SELL-36038.60037.280 37.412USD -13,468 34.31 Loss of -1,115 on sale
2025-11-24SELL-36038.00036.165 36.349USD -13,085 34.30 Loss of -738 on sale
2025-11-17SELL-1,32033.98032.135 32.319USD -42,662 34.31 Profit of 2,621 on sale
2025-11-12SELL-12034.38032.570 32.751USD -3,930 34.33 Profit of 190 on sale
2025-11-06SELL-12032.16031.430 31.503USD -3,780 34.38 Profit of 345 on sale
2025-11-05SELL-1,20033.41531.955 32.101USD -38,521 34.39 Profit of 2,746 on sale
2025-11-04SELL-24034.55532.720 32.904USD -7,897 34.40 Profit of 359 on sale
2025-11-03SELL-24035.06533.195 33.382USD -8,012 34.40 Profit of 244 on sale
2025-10-28BUY36036.45037.160 37.089USD 13,352 34.38
2025-10-24SELL-12037.54037.830 37.801USD -4,536 34.36 Loss of -413 on sale
2025-10-15BUY72037.03037.280 37.255USD 26,824 34.24
2025-10-02BUY12034.29035.000 34.929USD 4,191 34.24
2025-09-30BUY24035.25035.460 35.439USD 8,505 34.23
2025-09-11BUY48037.56037.660 37.650USD 18,072 34.19
2025-08-21SELL-12035.73036.240 36.189USD -4,343 34.19 Loss of -240 on sale
2025-07-31BUY35735.10035.780 35.712USD 12,749 34.17
2025-06-30SELL-23832.77032.850 32.842USD -7,816 34.55 Profit of 407 on sale
2025-06-25SELL-11932.27033.000 32.927USD -3,918 34.59 Profit of 198 on sale
2025-06-20SELL-24031.40031.940 31.886USD -7,653 34.65 Profit of 663 on sale
2025-05-30SELL-12,14934.57034.760 34.741USD -422,068 34.80 Profit of 740 on sale
2025-05-23BUY16132.71033.090 33.052USD 5,321 34.86
2025-05-19SELL-16132.40032.680 32.652USD -5,257 34.92 Profit of 365 on sale
2025-05-15SELL-48332.30032.590 32.561USD -15,727 34.96 Profit of 1,160 on sale
2025-05-12SELL-16131.81032.910 32.800USD -5,281 35.05 Profit of 362 on sale
2025-05-09SELL-16130.99031.590 31.530USD -5,076 35.08 Profit of 572 on sale
2025-04-30SELL-16129.91031.980 31.773USD -5,115 35.43 Profit of 589 on sale
2025-04-24SELL-32233.75033.820 33.813USD -10,888 35.50 Profit of 542 on sale
2025-04-17SELL-16132.01033.500 33.351USD -5,370 35.68 Profit of 375 on sale
2025-04-15SELL-48332.36033.560 33.440USD -16,152 35.75 Profit of 1,118 on sale
2025-04-14SELL-48632.62032.900 32.872USD -15,976 35.79 Profit of 1,417 on sale
2025-04-09SELL-64833.10034.310 34.189USD -22,154 35.91 Profit of 1,114 on sale
2025-04-07SELL-1,13431.59033.100 32.949USD -37,364 36.02 Profit of 3,483 on sale
2025-04-04SELL-1,62031.31032.150 32.066USD -51,947 36.08 Profit of 6,496 on sale
2025-03-31BUY16232.26032.550 32.521USD 5,268 36.18
2025-03-19SELL-32434.82035.170 35.135USD -11,384 36.40 Profit of 411 on sale
2025-03-14SELL-97233.31033.760 33.715USD -32,771 36.52 Profit of 2,724 on sale
2025-03-13SELL-32432.76033.690 33.597USD -10,885 36.57 Profit of 964 on sale
2025-03-12SELL-5,50832.69034.540 34.355USD -189,227 36.63 Profit of 12,516 on sale
2025-03-07SELL-32434.52036.150 35.987USD -11,660 36.75 Profit of 246 on sale
2025-03-06SELL-48636.25038.200 38.005USD -18,470 36.75 Loss of -608 on sale
2025-03-03SELL-16238.96039.710 39.635USD -6,421 36.68 Loss of -479 on sale
2025-02-28SELL-97238.74038.930 38.911USD -37,821 36.64 Loss of -2,203 on sale
2025-02-26SELL-16239.93040.670 40.596USD -6,577 36.56 Loss of -654 on sale
2025-02-25SELL-48639.43039.930 39.880USD -19,382 36.51 Loss of -1,639 on sale
2025-02-18BUY81038.22040.770 40.515USD 32,817 36.29
2025-02-13BUY16239.59042.080 41.831USD 6,777 36.04
2025-02-12BUY16242.36042.680 42.648USD 6,909 35.91
2025-02-11BUY48641.51041.930 41.888USD 20,358 35.80
2025-02-06BUY1,45840.96041.770 41.689USD 60,783 35.43
2025-01-27BUY16240.84041.300 41.254USD 6,683 34.24
2024-12-30BUY81030.25030.670 30.628USD 24,809 34.09
2024-12-06BUY64834.25034.790 34.736USD 22,509 34.10
2024-12-05BUY16234.11036.360 36.135USD 5,854 34.10
2024-12-04BUY81036.31036.930 36.868USD 29,863 34.02
2024-11-29BUY81036.16037.250 37.141USD 30,084 33.73
2024-11-27BUY64836.17036.470 36.440USD 23,613 33.51
2024-11-26BUY16235.79036.710 36.618USD 5,932 33.41
2024-11-25BUY6,88536.01036.320 36.289USD 249,850 33.29
2024-11-21BUY70535.68036.450 36.373USD 25,643 33.03
2024-11-20BUY42336.03036.280 36.255USD 15,336 32.87
2024-11-18BUY1,69234.72036.000 35.872USD 60,695 32.53
2024-11-12BUY1,12836.63038.210 38.052USD 42,923 32.26
2024-11-08BUY70537.45038.270 38.188USD 26,923 31.89
2024-11-07BUY2,11537.36037.770 37.729USD 79,797 31.47
2024-11-06BUY28237.62037.740 37.728USD 10,639 30.96
2024-10-31BUY14133.18035.190 34.989USD 4,933 29.46
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ATRC

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1975,7640170,36544.5%
2025-09-1868,15017148,53945.9%
2025-09-1748,7910104,89846.5%
2025-09-16147,2710190,38077.4%
2025-09-15233,4780319,06673.2%
2025-09-12193,5940286,13867.7%
2025-09-11256,8970327,48978.4%
2025-09-10112,45530233,60948.1%
2025-09-09111,4310139,76479.7%
2025-09-0871,6260145,78049.1%
2025-09-0545,694089,38751.1%
2025-09-0452,064096,30154.1%
2025-09-03135,4330192,54570.3%
2025-09-02107,7591,850176,49561.1%
2025-08-2955,705095,37658.4%
2025-08-2858,317091,02464.1%
2025-08-2725,898058,26044.5%
2025-08-2675,1030101,68573.9%
2025-08-2599,5450129,03977.1%
2025-08-22156,3280201,03677.8%
2025-08-2160,501082,91873.0%
2025-08-2082,6380129,29863.9%
2025-08-19146,2350190,74176.7%
2025-08-18107,6950175,57661.3%
2025-08-1573,2770113,49464.6%
2025-08-14101,4890146,41769.3%
2025-08-1392,7780135,20568.6%
2025-08-1263,3612182,03034.8%
2025-08-11101,1051,225267,49737.8%
2025-08-0866,5840127,31152.3%
2025-08-07109,8390173,94763.1%
2025-08-06155,8470248,43962.7%
2025-08-05174,6010279,09962.6%
2025-08-04310,7590385,35280.6%
2025-08-01162,340600255,82163.5%
2025-07-31172,0730285,81760.2%
2025-07-30845,1852,5571,422,49559.4%
2025-07-29132,6080284,22946.7%
2025-07-28272,5800451,79960.3%
2025-07-25106,8983202,92652.7%
2025-07-2466,1690155,27042.6%
2025-07-23113,1250207,97854.4%
2025-07-2295,3070153,04762.3%
2025-07-2176,9310130,82658.8%
2025-07-1864,716097,34366.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy